search
Back to results

Peritoneal Dialysis vs Furosemide for Acute Kidney Injury After Cardiopulmonary Bypass

Primary Purpose

Acute Kidney Injury

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Furosemide
Peritoneal Dialysis
Sponsored by
Children's Hospital Medical Center, Cincinnati
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Acute Kidney Injury focused on measuring Acute kidney injury, AKI, cardiopulmonary bypass

Eligibility Criteria

undefined - 6 Months (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age less than 6 months of age;
  • Undergoing cardiothoracic surgery with CPB;
  • Planned placement of PD catheter per institutional standard of care criteria.

Exclusion Criteria:

  • Pre-existing chronic kidney disease stage 3 or above (correlating with estimated GFR<60 ml/min/m2, which will be calculated using routine preoperative serum creatinine value using the modified Schwartz equation).
  • Known history of allergy to furosemide.

Sites / Locations

  • Cincinnati Childrens Hospital Medical Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Furosemide

Peritoneal dialysis

Arm Description

Patients randomized to the furosemide arm will be given 1 mg/kg intravenously every 6 hours for 2 doses and then as directed by CICU attending to augment urine output. Patients within this arm who have urine output <1 ml/kg/hr over 16 hours after the first dose of Lasix will be considered poor responders. These patients may be started on PD if clinically indicated. Those who show good response (urine output >1 ml/kg/hr over subsequent 16 hours) will continue furosemide as needed to augment urine output. If they subsequently develop oliguria or fluid overload unresponsive to diuretic therapy, these patients may later be started on PD at discretion of CICU attending with consultation of nephrology service.

Patients within the PD arm will begin PD with a standardized dialysis plan of 10ml/kg of 1.5% Dianeal™ with 1 hours cycles (5 minute fill, 45 minute dwell and 10 minute drain). Further PD management will be directed by CICU attending and Nephrology service

Outcomes

Primary Outcome Measures

Number of Participants With Negative Fluid Balance on Postop Day 1
Difference of inputs and outputs, including urine output and PD drainage.

Secondary Outcome Measures

Respiratory Support Administered
Duration of initial course of postoperative mechanical ventilation
NGAL Concentration
Duration of Cardiac ICU Stay
Total days of initial postoperative stay in cardiac ICU
Duration of Hospital Stay
Total days of initial postoperative stay in hospital
All Cause Mortality
In-hospital mortality
Renal/Electrolyte Abnormalities
Total sum of renal and electrolyte abnormalities over the first 5 postoperative days as defined in the protocol
Doses of Potassium Chloride or Arginine Chloride Required
Total doses of potassium chloride or arginine chloride given during the first five postoperative days.
B-Natriuretic Peptide
BNP measured at 24 and 48 hours postoperatively
Modified Oxygenation Index
Product of Mean airway pressure delivered by mechanical ventilation and FiO2 of administered oxygen

Full Information

First Posted
September 20, 2012
Last Updated
May 4, 2017
Sponsor
Children's Hospital Medical Center, Cincinnati
search

1. Study Identification

Unique Protocol Identification Number
NCT01709227
Brief Title
Peritoneal Dialysis vs Furosemide for Acute Kidney Injury After Cardiopulmonary Bypass
Official Title
Early Renal Replacement Therapy vs. Furosemide for Neonates With Oliguria After Cardiopulmonary Bypass
Study Type
Interventional

2. Study Status

Record Verification Date
May 2017
Overall Recruitment Status
Completed
Study Start Date
October 2011 (undefined)
Primary Completion Date
June 2015 (Actual)
Study Completion Date
June 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Children's Hospital Medical Center, Cincinnati

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Acute kidney injury (AKI) after cardiopulmonary bypass (CPB) in infants is common and associated with poor outcomes. Peritoneal dialysis (PD) and furosemide have been used to attain negative fluid balance due to AKI induced oliguria, but have not been compared prospectively. The investigators will prospectively compare outcomes of infants with oliguria after CPB randomized to PD vs. furosemide with the hypothesis that infants receiving PD have superior outcomes.
Detailed Description
Background: Acute kidney injury (AKI) is a common postoperative complication after heart surgery with cardiopulmonary bypass (CPB). Multiple studies have demonstrated that patients with AKI have worse clinical outcomes, such as longer ventilation times and increased length of stay, which is thought to be secondary to associated oliguria and subsequent fluid overload. Studies suggest that early renal replacement therapy (RRT) via peritoneal dialysis (PD) may prevent fluid overload and therefore be a superior management to diuretic (i.e. furosemide) administration. However, there is no published evidence to suggest superiority or laboratory data available to guide decision making. Objective: Our primary objective is to determine if early institution of PD improves clinical outcomes compared to administration of furosemide in post-operative cardiac infants with acute kidney injury. We hypothesize that early initiation of PD will improve clinical outcomes. We will determine if these clinical outcomes will be better among good responders of furosemide compared to poor responders. We will determine if postoperative NGAL concentrations are predictive of poor response to furosemide. Design / Methods: The study will be a single-center randomized clinical trial among neonates undergoing cardiac surgery with CPB with planned placement of a PD catheter due to risk of AKI. If patients demonstrate oliguria within the first postoperative day, they will be randomized to early PD or trial of furosemide. Clinical and laboratory data will be collected and compared between groups.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acute Kidney Injury
Keywords
Acute kidney injury, AKI, cardiopulmonary bypass

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
73 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Furosemide
Arm Type
Experimental
Arm Description
Patients randomized to the furosemide arm will be given 1 mg/kg intravenously every 6 hours for 2 doses and then as directed by CICU attending to augment urine output. Patients within this arm who have urine output <1 ml/kg/hr over 16 hours after the first dose of Lasix will be considered poor responders. These patients may be started on PD if clinically indicated. Those who show good response (urine output >1 ml/kg/hr over subsequent 16 hours) will continue furosemide as needed to augment urine output. If they subsequently develop oliguria or fluid overload unresponsive to diuretic therapy, these patients may later be started on PD at discretion of CICU attending with consultation of nephrology service.
Arm Title
Peritoneal dialysis
Arm Type
Experimental
Arm Description
Patients within the PD arm will begin PD with a standardized dialysis plan of 10ml/kg of 1.5% Dianeal™ with 1 hours cycles (5 minute fill, 45 minute dwell and 10 minute drain). Further PD management will be directed by CICU attending and Nephrology service
Intervention Type
Drug
Intervention Name(s)
Furosemide
Other Intervention Name(s)
Lasix
Intervention Description
Patients randomized to the furosemide arm will be given 1 mg/kg intravenously every 6 hours for 2 doses and then as directed by CICU attending to augment urine output. Patients within this arm who have urine output <1 ml/kg/hr over 16 hours after the first dose of Lasix will be considered poor responders. These patients may be started on PD if clinically indicated. Those who show good response (urine output >1 ml/kg/hr over subsequent 16 hours) will continue furosemide as needed to augment urine output. If they subsequently develop oliguria or fluid overload unresponsive to diuretic therapy, these patients may later be started on PD at discretion of CICU attending with consultation of nephrology service.
Intervention Type
Procedure
Intervention Name(s)
Peritoneal Dialysis
Other Intervention Name(s)
PD
Intervention Description
Patients within the PD arm will begin PD with a standardized dialysis plan of 10ml/kg of 1.5% Dianeal™ with 1 hours cycles (5 minute fill, 45 minute dwell and 10 minute drain). Further PD management and discontinuation will be directed by CICU attending and Nephrology service.
Primary Outcome Measure Information:
Title
Number of Participants With Negative Fluid Balance on Postop Day 1
Description
Difference of inputs and outputs, including urine output and PD drainage.
Time Frame
Postop day 1
Secondary Outcome Measure Information:
Title
Respiratory Support Administered
Description
Duration of initial course of postoperative mechanical ventilation
Time Frame
Duration of postoperative intubation (average time approximately- 1 week)
Title
NGAL Concentration
Time Frame
Pre-op, and postop (2hr, 6hr, 12hr, 24hr, 48hr)
Title
Duration of Cardiac ICU Stay
Description
Total days of initial postoperative stay in cardiac ICU
Time Frame
Average 2 weeks
Title
Duration of Hospital Stay
Description
Total days of initial postoperative stay in hospital
Time Frame
Average 4 weeks
Title
All Cause Mortality
Description
In-hospital mortality
Time Frame
duration of hospitalization (an average of 2 weeks)
Title
Renal/Electrolyte Abnormalities
Description
Total sum of renal and electrolyte abnormalities over the first 5 postoperative days as defined in the protocol
Time Frame
Postop morning 1-5
Title
Doses of Potassium Chloride or Arginine Chloride Required
Description
Total doses of potassium chloride or arginine chloride given during the first five postoperative days.
Time Frame
Postop day 0-5
Title
B-Natriuretic Peptide
Description
BNP measured at 24 and 48 hours postoperatively
Time Frame
At 24hours and 48 hours postoperative
Title
Modified Oxygenation Index
Description
Product of Mean airway pressure delivered by mechanical ventilation and FiO2 of administered oxygen
Time Frame
at 24 and 48 hours postoperative

10. Eligibility

Sex
All
Maximum Age & Unit of Time
6 Months
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age less than 6 months of age; Undergoing cardiothoracic surgery with CPB; Planned placement of PD catheter per institutional standard of care criteria. Exclusion Criteria: Pre-existing chronic kidney disease stage 3 or above (correlating with estimated GFR<60 ml/min/m2, which will be calculated using routine preoperative serum creatinine value using the modified Schwartz equation). Known history of allergy to furosemide.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
David M Kwiatkowski, MD
Organizational Affiliation
Cinncinnati Children's Hospital Medical Center
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Catherine D Krawczeski, MD
Organizational Affiliation
Cinncinnati Children's Hospital Medical Center
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Stuart L Goldstein, MD
Organizational Affiliation
Cinncinnati Children's Hospital Medical Center
Official's Role
Study Director
Facility Information:
Facility Name
Cincinnati Childrens Hospital Medical Center
City
Cincinnati
State/Province
Ohio
ZIP/Postal Code
45223
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
De-identified patient data would be available to other researchers after publication of data at the discretion of the research team after communication with the PI
Citations:
PubMed Identifier
28241247
Citation
Kwiatkowski DM, Goldstein SL, Cooper DS, Nelson DP, Morales DL, Krawczeski CD. Peritoneal Dialysis vs Furosemide for Prevention of Fluid Overload in Infants After Cardiac Surgery: A Randomized Clinical Trial. JAMA Pediatr. 2017 Apr 1;171(4):357-364. doi: 10.1001/jamapediatrics.2016.4538.
Results Reference
derived
Links:
URL
http://www.cincinnatichildrens.org/service/c/cacn/default/
Description
Center for Acute Care Nephology at Cincinnati Childrens

Learn more about this trial

Peritoneal Dialysis vs Furosemide for Acute Kidney Injury After Cardiopulmonary Bypass

We'll reach out to this number within 24 hrs